| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Franchising > Business Management Case Study; Arbitration, Mediation or Litigation in Franchising Agreements |
|
Advice You - Business Management Case Study; Arbitration, Mediation or Litigation in Franchising Agreements
Executive management franchising teams in franchising companies must deci According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product de how they wish to handle disputes in the franchising agreement. More o ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ten than not clauses are put into the franchising agreements, which stipu lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. late how disputes between franchise stores and franchisees will be handle here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe Generally the parties agree in advance to handle such disputes in a cer d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro tain way. One of the most common ways, which saves both the Franchisor a ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc d the franchisee from extensive legal fees is to use an arbitration claus easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi e. Generally these arbitration clauses serve the franchisee as well beca nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically se litigation is so very costly and generally when a franchisee has a dis and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ pute it is because the business is not succeeding and therefore they will ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi have little if any money to fight the Franchisor in court. The Franchisor ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a also benefits and it prevents excessive lawsuit litigation and very high dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod awards from kangaroo courts with problematic juries. Am I saying that ar cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin bitrator is usually rule in favor of franchisees? Yes, more often then no tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen , I have found this to be the case. In the end however, it saves time an t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel money USUALLY for both parties although it appears some franchise compani ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust s have indeed found an exception. Do I recommend arbitration clauses in y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products franchising agreements? Actually I do and we always had them in our fran . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de hising agreements, ask your attorney. But mediation and litigation are a elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip lso options to binding arbitration clauses. Please consider this in 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How To Maximize Your Amount of Office Space Change Management and Decreases in Innovative Spirit Business Men, Lawmakers or Prosecutors; Who is the Most Honest?
|